Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Joel Elconin

81 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Earnings
  • News
  • Top Stories

Citigroup Investors Buy The Dip After Q3 Earnings: How PreMarket Prep ID’ed The Trade

By Joel Elconin
October 14, 2:27 PM
After the massive rally on Thursday, investors were in full “buy the dip” mode. Even if a company did not serve up the best third-quarter report, if the stock was in the red, all the better. 

C

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • Top Stories
  • Trading Ideas

Moderna Rallies On Merck Collaboration: Can Drugmaker Replace COVID Vaccine Revenue?

By Joel Elconin
October 12, 5:22 PM
In late 2020, when the world was searching for a vaccine or cure for COVID-19, the price action in Moderna Inc (NASDAQ: MRNA) was discussed frequently on Benzinga's PreMarket Prep show. 

MRK

Read More
3 minute read
  • Management
  • Markets
  • News
  • Opinion
  • Top Stories

Analysis: Why Investors Should Hope Jamie Dimon Is Wrong Again About The Markets

By Joel Elconin
October 12, 1:28 PM
On Monday, the CEO of one of the biggest banks in the world, Jamie Dimon of JPMorgan & Chase Co (NYSE: JPM) made a bearish statement

JPM

Read More
4 minute read
  • General
  • M&A
  • Opinion
  • Social Media
  • Top Stories
  • Trading Ideas

Analysis: Why Elon Musk Should Run — Not Walk — Away From Twitter Deal

By Joel Elconin
October 11, 12:57 PM
Even the richest person in the world makes a few mistakes. Similar to being in the markets, sometimes it is better to cut your losses and move on than to add on to a losing position.

APO

Read More
2 minute read
  • Earnings
  • News
  • Technicals
  • Top Stories
  • Trading Ideas

Is McCormick Stock Benefiting From ‘Seller Exhaustion’ After Q3 Earnings? PreMarket Prep Breaks It Down

By Joel Elconin
October 7, 12:40 PM
Third-quarter earnings season does not ramp up until next week, with some big banks announcing results.

HELE

Read More
2 minute read
  • Movers
  • Penny Stocks
  • Technicals
  • Top Stories
  • Trading Ideas

Trading Credit Suisse’s Technical Levels As Markets Sweat The Bank’s Future

By Joel Elconin
October 4, 6:03 PM
It is hard to imagine that Monday's news cycle on Credit Suisse Group AG (NYSE: CS) would have a positive impact on

CS

Read More
2 minute read
  • Top Stories

Charting Wells Fargo’s Rally After Upgrade By This Fellow Bank

By Joel Elconin
October 3, 4:23 PM
It's rare when one investment bank upgrades another financial institution, and that took place on Monday when Goldman Sachs upgraded Wells Fargo & Co (NYSE: WFC) m

WFC

Read More
2 minute read
  • Economics
  • Markets
  • Media
  • Small Cap
  • Trading Ideas

Is Rent-A-Center Getting Ahead Of Bad News? PreMarket Prep Takes A Look

By Joel Elconin
September 30, 3:37 PM
It seems that every day investors get a warning sign the Federal Reserve's efforts to slow down consumer spending and the entire economy is coming to fruition.

RCII

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • ESG
  • Markets
  • Price Target
  • Technicals
  • Top Stories
  • Trading Ideas
  • Upgrades

First Solar Loses Power After Analyst Upgrade: What The Stock Chart Says

By Joel Elconin
September 29, 5:40 PM
In a bull market or at least a day when the market has upside potential, an upgrade to an issue may instigate an oversized move higher.

FSLR

Read More
2 minute read
  • Biotech
  • General
  • Movers
  • Technicals
  • Top Stories
  • Trading Ideas

What The Biogen Chart Reveals As Stock Rallies Hard On Alzheimer’s Data

By Joel Elconin
September 28, 2:53 PM
Going back to at least December 2014, Biogen Inc (NASDAQ: BIIB) has been diligently working on drugs to cure Alzheimer's disease. Both the negative and positive data revealed over the years have instigated wild price gyrations in the issue.

BIIB

Posts pagination

Previous 1 … 4 5 6 … 9 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service